199 related articles for article (PubMed ID: 30360480)
1. The Decrease in Human Endogenous Retrovirus-H Activity Runs in Parallel with Improvement in ADHD Symptoms in Patients Undergoing Methylphenidate Therapy.
Cipriani C; Pitzianti MB; Matteucci C; D'Agati E; Miele MT; Rapaccini V; Grelli S; Curatolo P; Sinibaldi-Vallebona P; Pasini A; Balestrieri E
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30360480
[TBL] [Abstract][Full Text] [Related]
2. First evidence of HERV-H transcriptional activity reduction after methylphenidate treatment in a young boy with ADHD.
D'Agati E; Pitzianti M; Balestrieri E; Matteucci C; Sinibaldi Vallebona P; Pasini A
New Microbiol; 2016 Jul; 39(3):237-239. PubMed ID: 27704146
[TBL] [Abstract][Full Text] [Related]
3. Human endogenous retroviruses and ADHD.
Balestrieri E; Pitzianti M; Matteucci C; D'Agati E; Sorrentino R; Baratta A; Caterina R; Zenobi R; Curatolo P; Garaci E; Sinibaldi-Vallebona P; Pasini A
World J Biol Psychiatry; 2014 Aug; 15(6):499-504. PubMed ID: 24286278
[TBL] [Abstract][Full Text] [Related]
4. New Insights on the Effects of Methylphenidate in Attention Deficit Hyperactivity Disorder.
Pitzianti MB; Spiridigliozzi S; Bartolucci E; Esposito S; Pasini A
Front Psychiatry; 2020; 11():531092. PubMed ID: 33132928
[TBL] [Abstract][Full Text] [Related]
5. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
[TBL] [Abstract][Full Text] [Related]
6. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
7. Addition of methylphenidate to intensive dialectical behaviour therapy for patients suffering from comorbid borderline personality disorder and ADHD: a naturalistic study.
Prada P; Nicastro R; Zimmermann J; Hasler R; Aubry JM; Perroud N
Atten Defic Hyperact Disord; 2015 Sep; 7(3):199-209. PubMed ID: 25634471
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
[TBL] [Abstract][Full Text] [Related]
9. Seasonal Patterns of Medications for Treating Attention-Deficit/Hyperactivity Disorder: Comparison of Methylphenidate and Atomoxetine.
Shyu YC; Lee SY; Yuan SS; Yang CJ; Yang KC; Lee TL; Wang LJ
Clin Ther; 2016 Mar; 38(3):595-602. PubMed ID: 26874787
[TBL] [Abstract][Full Text] [Related]
10. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
[TBL] [Abstract][Full Text] [Related]
11. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
[TBL] [Abstract][Full Text] [Related]
12. The Possible Effect of Methylphenidate Treatment on Empathy in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder, Both With and Without Comorbid Oppositional Defiant Disorder.
Golubchik P; Weizman A
J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):429-432. PubMed ID: 28398816
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.
Pliszka SR; Wilens TE; Bostrom S; Arnold VK; Marraffino A; Cutler AJ; López FA; DeSousa NJ; Sallee FR; Incledon B; Newcorn JH
J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):474-482. PubMed ID: 29172680
[TBL] [Abstract][Full Text] [Related]
14. Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?
Golubchik P; Kodesh A; Weizman A
Clin Neuropharmacol; 2013; 36(5):141-5. PubMed ID: 24045603
[TBL] [Abstract][Full Text] [Related]
15. HERVs expression in Autism Spectrum Disorders.
Balestrieri E; Arpino C; Matteucci C; Sorrentino R; Pica F; Alessandrelli R; Coniglio A; Curatolo P; Rezza G; Macciardi F; Garaci E; Gaudi S; Sinibaldi-Vallebona P
PLoS One; 2012; 7(11):e48831. PubMed ID: 23155411
[TBL] [Abstract][Full Text] [Related]
16. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.
Angyal N; Horvath EZ; Tarnok Z; Richman MJ; Bognar E; Lakatos K; Sasvari-Szekely M; Nemoda Z
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):122-128. PubMed ID: 29374517
[TBL] [Abstract][Full Text] [Related]
17. Children With Autism Spectrum Disorder and Their Mothers Share Abnormal Expression of Selected Endogenous Retroviruses Families and Cytokines.
Balestrieri E; Cipriani C; Matteucci C; Benvenuto A; Coniglio A; Argaw-Denboba A; Toschi N; Bucci I; Miele MT; Grelli S; Curatolo P; Sinibaldi-Vallebona P
Front Immunol; 2019; 10():2244. PubMed ID: 31616420
[TBL] [Abstract][Full Text] [Related]
18. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up.
Su Y; Yang L; Stein MA; Cao Q; Wang Y
J Child Adolesc Psychopharmacol; 2016 May; 26(4):362-71. PubMed ID: 26779845
[TBL] [Abstract][Full Text] [Related]
19. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
20. Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial.
Zeni CP; Tramontina S; Ketzer CR; Pheula GF; Rohde LA
J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):553-61. PubMed ID: 19877980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
